Clinical trial
Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell…
NCT00003924 · Lymphoma Study Association, Other · Unknown status
Key facts
| NCT number | NCT00003924 |
|---|---|
| Title | Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma |
| Official title | A European Randomized Multicenter Study of Interferon Alfa-2b Versus No Treatment After Intensive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Relapsing Lymphoma Patients (Non-Hodgkin Lymphomas and Hodgkin's Disease) |
| Lead sponsor | Lymphoma Study Association, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | recombinant interferon alfa |
| Enrollment | 360 |
| Start date | Oct 1, 1995 |
| First posted | May 20, 2004 |
| Last update posted | Aug 7, 2013 |
| Countries | France, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: